What is the appropriate confirmatory test for a patient with hypocortisolism (low morning cortisol level)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Confirmatory Test for Low Morning Cortisol

The ACTH (cosyntropin) stimulation test is the appropriate confirmatory test for a patient with a low morning cortisol level, using 0.25 mg cosyntropin administered intramuscularly or intravenously, with cortisol measurements at baseline and 30 minutes post-administration. 1, 2

Diagnostic Algorithm

Step 1: Interpret the Morning Cortisol Level

  • Morning cortisol <250 nmol/L (<9 μg/dL) with elevated ACTH in acute illness is diagnostic of primary adrenal insufficiency and may not require further testing if clinical context is clear 1
  • Morning cortisol <275 nmol/L (<10 μg/dL) warrants confirmatory ACTH stimulation testing 3
  • Morning cortisol >13 μg/dL reliably rules out adrenal insufficiency without need for further testing 4
  • Cortisol levels between these thresholds require ACTH stimulation testing for definitive diagnosis 1, 3

Step 2: Measure Baseline ACTH Simultaneously

  • Obtain morning (8-9 AM) plasma ACTH along with cortisol to distinguish primary from secondary adrenal insufficiency 1
  • Low cortisol with high ACTH indicates primary adrenal insufficiency (adrenal gland failure) 1
  • Low cortisol with low or inappropriately normal ACTH indicates secondary adrenal insufficiency (pituitary/hypothalamic dysfunction) 1

Step 3: Perform ACTH Stimulation Test

Standard Protocol (High-Dose Test): 1, 2

  • Administer 0.25 mg (250 mcg) cosyntropin intramuscularly or intravenously 1, 2
  • Obtain baseline serum cortisol immediately before administration 2
  • Measure serum cortisol at 30 minutes and optionally at 60 minutes post-injection 1, 2
  • Peak cortisol <500 nmol/L (<18 μg/dL) is diagnostic of adrenal insufficiency 1, 3, 2
  • Peak cortisol >550 nmol/L (>20 μg/dL) is considered normal and rules out adrenal insufficiency 1, 3

Alternative Low-Dose Test (1 mcg): 5, 6

  • The 1 mcg test is more sensitive for secondary adrenal insufficiency but requires dilution of the commercial preparation at bedside, making it less practical 1, 5
  • Use a cutoff of 550 nmol/L at 30 minutes for optimal sensitivity (97%) and specificity (78%) 6
  • The high-dose test is recommended over the low-dose test due to easier administration, comparable diagnostic accuracy, and FDA approval 1

Critical Considerations Before Testing

When to Skip Testing and Treat Immediately

  • Never delay treatment in suspected acute adrenal crisis—give IV hydrocortisone 100 mg immediately plus 0.9% saline infusion without waiting for test results 1, 3
  • Clinical features requiring immediate treatment include unexplained hypotension, collapse, or gastrointestinal symptoms (vomiting/diarrhea) 1
  • Vasopressor-resistant hypotension should prompt empiric stress-dose hydrocortisone 1

Medications That Interfere With Testing

  • Stop glucocorticoids and spironolactone on the day of testing as they falsely elevate cortisol levels 2
  • Long-acting glucocorticoids may need to be stopped for a longer period before testing 2
  • Stop estrogen-containing drugs 4-6 weeks before testing to allow cortisol-binding globulin levels to normalize 2
  • Exogenous steroids including inhaled fluticasone can suppress the HPA axis and confound results 1, 3
  • If you must treat suspected adrenal crisis but still want to perform diagnostic testing later, use dexamethasone 4 mg IV instead of hydrocortisone, as dexamethasone does not interfere with cortisol assays 1

Conditions Affecting Cortisol-Binding Globulin

  • Pregnancy, oral estrogens, and chronic hepatitis increase cortisol-binding globulin and falsely elevate total cortisol 3, 2
  • Cirrhosis and nephrotic syndrome decrease cortisol-binding globulin and falsely lower total cortisol 3, 2
  • Consider measuring cortisol-binding globulin levels if these conditions are present to ensure accurate interpretation 2

Common Pitfalls to Avoid

  • Do not rely on electrolyte abnormalities alone—hyperkalemia is present in only ~50% of primary adrenal insufficiency cases, and hyponatremia can occur in both primary and secondary forms 1, 3
  • The absence of hyperkalemia cannot rule out adrenal insufficiency 1, 3
  • Patients taking ≥20 mg/day prednisone or equivalent for at least 3 weeks who develop unexplained hypotension should be presumed to have adrenal insufficiency until proven otherwise 1
  • Testing for HPA axis recovery should wait until 3 months after stopping chronic corticosteroid therapy 1
  • In patients on ongoing steroid therapy with clinical uncertainty, opt for empiric glucocorticoid replacement and test for ongoing need at 3 months rather than attempting diagnostic testing while on steroids 1

Post-Diagnosis Management

  • If adrenal insufficiency is confirmed, all patients require education on stress dosing, emergency injectable hydrocortisone, and a medical alert bracelet 7, 1
  • Early endocrinology consultation is appropriate for treatment planning and patient education 7, 1
  • Primary adrenal insufficiency requires both glucocorticoid and mineralocorticoid (fludrocortisone) replacement, while secondary adrenal insufficiency requires only glucocorticoids 1

References

Guideline

Diagnosing Adrenal Insufficiency in Hypo-osmolar Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cortisol Level Interpretation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosing adrenal insufficiency: which test is best--the 1-microg or the 250-microg cosyntropin stimulation test?

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.